Lifestyle
Building a Sustainable Approach to Should I Worry About My Fasting Insulin Result?
Most standard lab panels never order fasting insulin — and when it does appear, your doctor may tell you it's 'normal' even when it's quietly predicting metabolic trouble years ahead. Understanding what your fasting insulin number actually means, and what to do about it, could be one of the most important steps you take for your long-term health.
Should I Worry About My Fasting Insulin Result?
You opened your lab results, spotted a number next to 'fasting insulin,' and now you're not sure whether to be relieved or alarmed. You're not alone. Fasting insulin is one of the most underordered and misunderstood markers in routine blood work — yet it may be the single earliest warning signal for insulin resistance, cardiovascular risk, and type 2 diabetes, often appearing years or even decades before fasting glucose climbs out of range.
This article walks you through how to interpret your fasting insulin result, what context you need to make sense of it, and when — and how — to take action.
---
What Is Fasting Insulin and Why Does It Matter?
Insulin is a hormone secreted by the beta cells of the pancreas in response to rising blood glucose. After a carbohydrate-containing meal, blood sugar rises, insulin spikes, glucose is shuttled into cells, and both return to baseline. When you measure insulin after an overnight fast (typically 8–12 hours with no calories), you're capturing the basal or resting secretory rate — what your pancreas is doing when it theoretically has nothing urgent to manage.
A high fasting insulin tells you that your pancreas is working overtime just to keep blood sugar in check. This state — called hyperinsulinemia — is the biochemical signature of insulin resistance. Your cells have downregulated their response to insulin's signal, so the pancreas compensates by producing more of it. Over time, this compensation fails, blood glucose rises, and the diagnosis of prediabetes or type 2 diabetes follows.
The problem is that most people spend 10–15 years in the hyperinsulinemic, normal-glucose phase before fasting glucose ever becomes abnormal. That window is your best opportunity to reverse course.
---
What Is a Normal Fasting Insulin Level?
Here is where things get genuinely confusing. Most laboratory reference ranges list fasting insulin as normal up to 24–25 µIU/mL (174 pmol/L). However, functional medicine clinicians and metabolic researchers routinely use a much tighter target:
| Category | Fasting Insulin (µIU/mL) | Clinical Interpretation |
|---|---|---|
| Optimal | 2–6 | Excellent insulin sensitivity |
| Acceptable | 6–10 | Generally healthy, monitor trends |
| Borderline | 10–15 | Early insulin resistance likely |
| Elevated | 15–25 | Significant insulin resistance |
| High (lab 'normal') | >25 | Overt hyperinsulinemia |
A 2019 analysis published in Diabetologia found that fasting insulin above 9–10 µIU/mL in non-diabetic adults was independently associated with a significantly elevated risk of incident type 2 diabetes over 10 years, even when fasting glucose was still normal (Tabák et al., Diabetologia 2009; PMID: 19169660). The takeaway: your lab's 'normal' range and your optimal range are not the same thing.
---
Should I Worry About My Fasting Glucose Result?
Fasting insulin and fasting glucose are related but tell different stories. Fasting glucose reflects the outcome of insulin's work; fasting insulin reflects the effort required. You can have a perfectly normal fasting glucose (below 100 mg/dL) while your fasting insulin is already elevated — a state sometimes called 'normoglycemic insulin resistance.'
Optimal fasting glucose is generally considered to be 70–90 mg/dL. The standard prediabetes cutoff begins at 100 mg/dL (impaired fasting glucose) and diabetes at 126 mg/dL. But research suggests that risk begins to climb even within the 'normal' range: a 2010 meta-analysis in The Lancet demonstrated that fasting plasma glucose levels as low as 75 mg/dL were associated with progressively higher cardiovascular risk (Emerging Risk Factors Collaboration, Lancet 2010; PMID: 20609965).
The most powerful way to use these two markers together is to calculate the HOMA-IR score:
> HOMA-IR = (Fasting Insulin µIU/mL × Fasting Glucose mg/dL) ÷ 405
A HOMA-IR above 1.9 suggests early insulin resistance; above 2.9 is significant insulin resistance. This simple formula turns two separate lab values into a clinically actionable single number.
If your fasting glucose is creeping toward the high end of normal and your insulin is elevated, that's a stronger signal than either value alone — and a reason to act now, not wait for the formal prediabetes threshold.
---
Lifestyle Levers That Move Fasting Insulin
The good news is that fasting insulin is among the most modifiable of all metabolic biomarkers. The interventions with the strongest evidence include:
- Resistance training: A 12-week strength training protocol significantly reduced fasting insulin independent of weight loss in a randomized trial by Eriksson et al. (Diabetes Care 1997). Muscle tissue is the largest sink for glucose disposal, and building it improves insulin sensitivity at the receptor level.
- Dietary carbohydrate reduction: Lowering refined carbohydrate intake reduces postprandial glucose excursions and the resulting insulin demand. A 2021 systematic review in The BMJ found that low-carbohydrate diets produced significant reductions in fasting insulin at 6 months compared to low-fat controls (Gjuladin-Hellon et al., Nutrition Reviews 2019; PMID: 30535104).
- Time-restricted eating: Compressing your eating window (e.g., 16:8 or 14:10) reduces the cumulative daily insulin exposure and allows prolonged periods of low-insulin signaling, which supports fat oxidation. A randomized crossover study in Cell Metabolism found that early time-restricted eating improved insulin sensitivity in men with prediabetes (Sutton et al., Cell Metabolism 2018; PMID: 29754952).
- Sleep quality: Poor sleep acutely impairs insulin sensitivity. Even one week of sleep restriction to 5 hours per night reduced insulin sensitivity by ~25% in healthy volunteers (Nedeltcheva et al., Annals of Internal Medicine 2010; PMID: 21135216).
- Stress management: Chronic cortisol elevation promotes gluconeogenesis and peripheral insulin resistance. Managing psychological stress through mindfulness, breathing work, or adaptogenic support is a legitimate metabolic intervention, not just a wellness cliché.
Tracking your fasting insulin trends alongside wearable data — particularly sleep scores and activity metrics — gives you a feedback loop that's far more actionable than a once-a-year lab draw.
---
Should I Worry About My TSH Result? (And What Does Thyroid Have to Do With Insulin?)
This is a question worth addressing because thyroid dysfunction and insulin resistance are bidirectionally linked — and many people receiving one diagnosis have unrecognized disruption in the other system.
TSH (thyroid-stimulating hormone) is the pituitary's signal to the thyroid to produce more hormone. An elevated TSH suggests the thyroid is underperforming (hypothyroidism); a suppressed TSH suggests it may be overproducing (hyperthyroidism). Optimal TSH is generally 0.5–2.5 mIU/L for most adults, though this range is debated.
Here's the metabolic connection: hypothyroidism reduces the expression of GLUT4 transporters in muscle cells, which are the same channels that insulin uses to drive glucose uptake. Even subclinical hypothyroidism (TSH 2.5–10 with normal T4) has been associated with higher fasting insulin and HOMA-IR in population studies. If your fasting insulin is elevated and your TSH is creeping above 2.5, it's worth investigating your full thyroid panel before attributing the insulin resistance solely to diet and lifestyle.
---
Should I Worry About My Free T4 and Free T3 Results?
Free T4 (thyroxine) is the primary storage hormone produced by the thyroid; free T3 (triiodothyronine) is the active form that enters cells and drives metabolic rate. T4 is converted to T3 peripherally in tissues like the liver, muscle, and gut. Suboptimal conversion — yielding low-normal free T3 with normal T4 — is a common but underappreciated pattern.
Why does this matter for your fasting insulin? T3 is directly involved in regulating basal metabolic rate, mitochondrial function, and glucose metabolism. Low T3 states reduce thermogenesis and caloric expenditure, making it easier to accumulate metabolic dysfunction even without overeating. Research has shown that free T3 in the lower quartile of the reference range is independently associated with features of metabolic syndrome, including higher fasting insulin (Roos et al., Clinical Endocrinology 2007; PMID: 17561964).
If you're asking should I worry about my free T3 result, the answer is: yes, if it's low-normal, especially in the context of elevated fasting insulin, fatigue, and difficulty losing weight. These patterns cluster together and point to overlapping metabolic and thyroid dysfunction that responds well to integrated support.
Learning to read your thyroid panel in full context — not just TSH in isolation — is one of the most valuable things you can do for your metabolic health assessment.
---
What This Means for Your Formula
When Ones analyzes your lab results, fasting insulin (if ordered) is treated as a tier-one metabolic signal. Elevated fasting insulin and signs of insulin resistance shift the formula toward ingredients with the strongest evidence for improving glucose metabolism and reducing the downstream consequences of hyperinsulinemia.
Relevant Ones ingredients for this context include:
- Berberine (500mg, clinical range 500–1500mg/day): A botanical alkaloid with extensive evidence for improving insulin sensitivity via AMPK activation, comparable in some trials to metformin for fasting glucose and HOMA-IR reduction. If your labs show elevated fasting insulin alongside borderline glucose, this is a meaningful therapeutic target.
- Chromium (Chromium Picolinate, 200–400mcg): Chromium is a cofactor for the insulin receptor signaling complex. Supplementation has been shown to reduce fasting insulin and improve HOMA-IR in insulin-resistant adults in several randomized trials.
- Ones Adrenal Support blend: Because cortisol dysregulation is a major upstream driver of insulin resistance, Ones includes its proprietary Adrenal Support system blend for users whose wearable and lab data suggest HPA axis overactivation — addressing the stress-insulin axis directly rather than treating glucose metrics in isolation.
Ones uses your full picture — not just one marker — to build a formula calibrated to your biology. Discovering an elevated fasting insulin on your panel is the beginning of a conversation, not the end of one.
---
Key Takeaways
- Fasting insulin is often more informative than fasting glucose — hyperinsulinemia can precede elevated blood sugar by 10–15 years, making it one of the earliest detectable metabolic warning signs.
- Optimal fasting insulin is 2–6 µIU/mL, well below most labs' upper reference limit of 24–25 µIU/mL; values above 10 warrant attention.
- Calculate your HOMA-IR by combining fasting insulin and fasting glucose — a result above 1.9 signals meaningful insulin resistance.
- Thyroid function and insulin sensitivity are linked: suboptimal free T3 and elevated TSH can independently worsen fasting insulin; always evaluate these systems together.
- Lifestyle interventions work: resistance training, carbohydrate reduction, time-restricted eating, and sleep optimization each have randomized trial evidence for lowering fasting insulin.
- Personalized supplementation — including targeted metabolic and adrenal support ingredients at clinical doses — can complement lifestyle changes when your lab data indicates the need.